Giuseppe De Vincenzo appointed to head CEVA’s South Pacific (SOPAC) operations

>> Wednesday, October 28, 2009

MELBOURNE, Australia– CEVA Logistics, a leading global supply chain management company, has today announced the appointment of Giuseppe De Vincenzo as its new Executive Vice President - designate for the South Pacific (SOPAC) business, which encompasses Australia and New Zealand.


De Vincenzo, who will take up the position permanently on 1 January 2010, has been with the company for the past seven years, most recently as the company’s Vice President, Brazil. Prior to this, he was the Managing Director of contract logistics, South America. He brings a wealth of international operating experience to the role, including a strong automotive background having previously worked for Fiat and Nissan prior to joining CEVA.

Commenting on his new role, Mr De Vincenzo said: “I am looking forward to driving the next stage of growth and realising the company’s ambitious business goals for our SOPAC operations through strong company performance. This will involve further expanding and leveraging our unique range of supply chain service solutions to existing and new customers across the region.
De Vincenzo will succeed Howard Critchley, who has announced his impending retirement from full-time work with the company after 14 years of service. During this time, Mr Critchley has overseen development of the SOPAC business into a world class provider of integrated contract logistics and freight management services. In 2005, he took over the management of the company’s Asian logistics business (Thailand, Indonesia and Malaysia) and in 2006 the China logistics activities before his current appointment as the Regional Vice President, SOPAC in 2007. From 1 January 2010, Mr Critchley will leave his current position and take up a consultancy role with CEVA, focused on growing the company’s contract logistics footprint in several key markets across the Asia Pacific region, including India and other north Asian countries.

0 comments:

Back to TOP